HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs

Kathleen A. McGinnis, Melissa Skanderson, Amy C. Justice, Kathleen M. Akgün, Janet P. Tate, Joseph T. King, Christopher T. Rentsch, Vincent C. Marconi, Evelyn Hsieh, Christopher Ruser, Farah Kidwai‐Khan, Roozbeh Yousefzadeh, Joseph Erdos, Lesley S. ParkJournal of the International AIDS Society 2021 · DOI

TL;DR

This study examines how the US Department of Veterans Affairs (VA) adapted HIV care during the COVID-19 pandemic, finding a significant shift towards virtual visits and longer antiretroviral (ARV) prescription refills. Despite reduced in-person interactions, HIV viral load suppression remained high, and ARV access was maintained, suggesting the effectiveness of differentiated service delivery models.

What Problem Does This Paper Address?

The COVID-19 pandemic necessitated rapid changes in healthcare delivery across the globe. For individuals living with HIV (PLWH), maintaining consistent care, including regular ARV medication adherence and viral load (VL) monitoring, is crucial for managing the virus and preventing transmission. The pandemic posed a significant challenge to these established care pathways, potentially disrupting access to services due to lockdowns, fear of infection, and strained healthcare resources. This paper investigates how the VA, a major provider of HIV care in the US, navigated these challenges by examining changes in HIV healthcare delivery during the first year of the pandemic compared to a pre-pandemic period. Specifically, it explores the impact on virtual care adoption, ARV access, and VL management within this large veteran population.

Methods

The researchers conducted a retrospective cohort study using data from the Veterans Aging Cohort Study (VACS), a national dataset of US veterans. They analyzed data from 27,674 PLWH who were enrolled in VACS prior to March 2019 and had at least one healthcare encounter in either the pre-pandemic period (March 2019 - February 2020) or the pandemic period (March 2020 - February 2021).

Key metrics analyzed included:

  • General Medicine/Infectious Disease (GM/ID) clinic visits: Differentiating between in-person and virtual (telephone/video) encounters.
  • HIV-1 RNA viral load (VL) tests: Categorized by detectable and suppressed levels.
  • Antiretroviral (ARV) medication refills: Summarized by refill length (<90 days vs. ≥90 days) and monthly ARV coverage.
  • Screening for alcohol and tobacco use: Assessed through clinical reminders and diagnoses.

The study compared these metrics between the two time periods and also explored variations by race/ethnicity and gender.

Datasets

The primary dataset used was the Veterans Aging Cohort Study (VACS), a national cohort of over 60,000 PLWH and matched controls. Data was extracted from the VA Corporate Data Warehouse, a comprehensive repository of clinical and administrative data from the US Department of Veterans Affairs.

Key Insights and Ideas

  • Rapid and successful pivot to virtual care: The VA demonstrated a remarkable ability to rapidly scale up virtual healthcare services, with a dramatic increase in virtual visits for HIV care. This highlights the potential of telehealth to maintain care continuity during public health crises.
  • Differentiated service delivery as a resilience factor: The study suggests that pre-existing differentiated service delivery models, such as mail-order pharmacy for ARVs and the infrastructure for virtual visits, were crucial in maintaining access to care and preventing disruptions during the pandemic.
  • Sustained viral suppression despite reduced testing: A key finding is that while the number of VL tests decreased during the pandemic, the proportion of patients with suppressed VL remained high among those tested. This indicates that the core goal of viral suppression was largely maintained.
  • Gender disparities persist and may be exacerbated: The study identified that women with HIV were less likely than men to have in-person visits, VL measured, and ARV coverage, both before and during the pandemic. This suggests that existing gender-based disparities in HIV care require targeted interventions.
  • Screening for substance use declined: A notable negative finding was the significant decrease in alcohol and tobacco use screening during the pandemic, likely due to the shift away from in-person visits where these screenings were often integrated. This highlights a potential area for improvement in future virtual care models.

Key Results

  • Virtual visits surged: The percentage of virtual GM/ID clinic visits increased from 27% in the pre-pandemic period to 64% during the first year of the pandemic.
  • ARV refills lengthened: The proportion of ARV refills for ≥90 days increased from 39% to 51% between the two periods.
  • Viral load suppression remained high: Among those with VL measured, 92% had suppressed VL in the pre-pandemic period, and 91% had suppressed VL during the pandemic.
  • VL testing decreased: Overall VL testing decreased from 82% of patients in the pre-pandemic period to 74% during the pandemic.
  • ARV coverage remained stable: Despite fewer refills, ARV coverage remained consistent, ranging from 76% to 80% across most months in both periods.
  • Gender differences: Women were consistently less likely than men to have in-person visits (91% vs. 95% pre-pandemic, 77% vs. 80% pandemic), VL measured (73% vs. 82% pre-pandemic, 67% vs. 74% pandemic), and ARV coverage (75% vs. 85% pre-pandemic, 74% vs. 85% pandemic).
  • Substance use screening declined: The percentage of patients screened for AUDIT-C dropped from 75% to 60%, and tobacco use screening dropped from 74% to 60%.

Limitations and Future Work

The authors acknowledge several limitations:

  • Exclusion of vulnerable populations: Individuals who died or tested positive for SARS-CoV-2 during the study period were excluded, potentially missing data on particularly vulnerable PLWH.
  • Generalizability to non-VA populations: The study focused on veterans, and findings for women may not generalize to non-VA populations due to the predominantly male veteran population.
  • Interpretation of missing VL data: The increase in patients without a measured VL in 2020 warrants caution, as this could be linked to lower ARV use.

Future work suggested includes:

  • Longer-term follow-up: To assess the impact of differentiated service delivery on overall health outcomes and to determine if a long-term shift to increased virtual healthcare is beneficial, especially for those in rural areas or with transportation barriers.
  • Targeted interventions for women: Programmes to increase ARV use and VL testing for women are needed.
  • Evaluation of newly diagnosed PLWH: Investigating whether newly diagnosed PLWH faced greater challenges in achieving VL suppression during the pandemic.
  • Assessment of substance use screening: Further research is needed to evaluate the assessment and treatment of HIV and substance use during the COVID-19 pandemic, and to explore efficient ways to integrate substance use screening into virtual care models.

Summary updated

Abstract

During the COVID-19 pandemic, the VA increased the use of virtual visits and longer ARV refills, while maintaining a high percentage of patients with suppressed VL among those with VL measured. Despite decreased in-person services during the pandemic, access to ARVs was not disrupted. More follow-up time is needed to determine whether overall health was impacted by the use of differentiated service delivery and to evaluate whether a long-term shift to increased virtual healthcare could be beneficial, particularly for PWH in rural areas or with transportation barriers. Programmes to increase ARV use and VL testing for women are needed.
BibTeX
@article{mcginnis2021hiv,
  author = {Kathleen A. McGinnis and Melissa Skanderson and Amy C. Justice and Kathleen M. Akgün and Janet P. Tate and Joseph T. King and Christopher T. Rentsch and Vincent C. Marconi and Evelyn Hsieh and Christopher Ruser and Farah Kidwai‐Khan and Roozbeh Yousefzadeh and Joseph Erdos and Lesley S. Park},
  title = {{HIV care using differentiated service delivery during the COVID‐19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs}},
  journal = {Journal of the International AIDS Society},
  year = {2021},
  doi = {10.1002/jia2.25810},
}
Figure